Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Undervalued vs peers
About
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITDA, trading a
Target Price
The average target price of MVF.AX is 0.81 and suggests 16.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in